x
Breaking News
More () »

13 WTHR Indianapolis | Indianapolis Local News & Weather

ISDH details Indiana COVID-19 vaccine rollout plans

There will be 50 hospitals administering the vaccine at first, and then expand.

INDIANAPOLIS — The Indiana State Department of Health plan to distribute the COVID-19 vaccine will roll out in multiple phases.

Phase 1-A

The purpose of this phase of the vaccine rollout is to reinforce and support the health care infrastructure. This group includes all paid and unpaid persons serving in health care settings who have the potential for direct or indirect exposure to patients or infectious material.

Health care settings include, but are not limited to: hospitals, long-term care facilities, outpatient facilities, home health care settings, pharmacies, dialysis centers, emergency medical services, frontline public health interventions, and COVID-19 diagnostic and immunization teams.

Licensed and non-licensed health care workers are included in this group:

  • Nurses, physicians, RT, PT/OT, speech therapists, pharmacy, imaging, laboratory, social services, case management, non-traditional providers (doulas, midwives), chaplain services, dental providers, emergency medical services 
  • EVS, dietary, maintenance, security, other patient facing ancillary staff.

Health care workers will receive registration information to schedule a time to get a vaccine. They will have to provide an ID and proof they work in health care.

There will be 50 hospitals administering the vaccine, and health care workers will be assigned based on where they live. For some, that might be one location, while others might be able to choose from multiple locations.

There will be no charge to the person receiving the vaccine, but insurance information will be needed. This is because there might be a $28 administration fee charged to insurance. The state ensures there will be no co-pay or charge to those who do not have insurance.

Once a health care worker receives their vaccination, an appointment will be set up to get the second dose in 21 days (Pfizer vaccine) or 28 days (Moderna vaccine).

Phase 1-B 

This phase will focus on protecting those who are most vulnerable to the virus.

  • Individuals who are at particular risk of morbidity and mortality associated with COVID-19, based on the latest evidence-based criteria.

This is the CDC's list of increased risk medical conditions: 

  • Cancer 
  • Chronic kidney disease 
  • COPD
  • Immunocompromised state from solid organ transplant 
  • Obesity 
  • Serious heart conditions 
  • Sickle cell disease 
  • Type 2 diabetes 

This is the CDC's list of likely to increase risk medical conditions: 

  • Asthma (moderate-to-severe) 
  • Cerebrovascular disease 
  • Cystic fibrosis 
  • Hypertension
  • Immunocompromised state from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, or use of other immune weakening medications. 
  • Neurologic conditions, such as dementia 
  • Liver disease 
  • Pregnancy
  • Pulmonary fibrosis 
  • Smoking
  • Thalassemia 
  • Type 1 diabetes mellitus

This phase could include expanding beyond the 50 hospitals to local health departments, pharmacies and mobile response teams.

The state has said it anticipates completing Phase 1-A and 1-B around the end of December.

Phase 2

The focus of Phase 2 is to mitigate spread. The following individuals will be able to receive the vaccine during Phase 2:

  • Persons living or working in prisons, jails, detention centers, and similar facilities 
  • Persons living or working in group homes or shelters, including but not limited to homeless shelters, domestic violence shelters, or group homes for persons with physical or mental disabilities or in recovery
  • Individuals whose in-person work is essential, required, and places them in settings where social distancing is not possible and transmission risk is high:
    • Fire and Police 
    • Food service 
    • Retail 
    • Public transportation 
    • Utilities 
    • Public health 
    • Manufacturing/construction (indoors) 
    • School teachers 
    • Warehouse

Phase 3

This phase of the vaccine focuses on the general public being vaccinated. Here are the key characteristics of Phase 3:

  • Likely sufficient COVID-19 vaccine supply where supply might exceed demand
  • Broad vaccine administration network for increased access 
  • Increased emphasis on redistribution of existing vaccine

The read the entire state plan for COVID vaccine distribution, click here.